Dose-dependent bioavailability, absorption-rate limited elimination, and tissue distribution of the ATR inhibitor BAY-1895344 (elimusertib) in mice is a research paper published in Cancer Chemotherapy and Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R50CA211241
National Cancer Institute
Grant: R01CA236367
National Cancer Institute
Grant: P30CA047904
National Institutes of Health
Grant: TL1TR001858
National Institutes of Health
Grant: 1R01CA236367-01A1
DNA damage signaling to dormant origins of replication
National Institutes of Health
Grant: 5R50CA211241-02
Cancer Pharmacokinetics Research Specialist
National Institutes of Health
Grant: 3TL1TR001858-07S1
Administrative Supplement to NIH-funded TL1 Training Grants
National Institutes of Health
Grant: 3P30CA047904-07S1
CANCER CENTER SUPPORT GRANT
FWCI
0.55
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals